Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.
The standardisation of terminology in lower urinary tract function: reportfrom the standardisation sub-committee of the International ContinenceSociety.
The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence Society
The standardisation of terminology of lower urinary tract function: Report from the standardistation sub-committee of the International Continence Society.
The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.
This report restates the ICS principle that symptoms, signs and conditions are separate categories and adds a category of urodynamic observations and conditions associated with lower urinary tract dysfunction and UDS, for use in all patient groups from children to the elderly.
How widespread are the symptoms of an overactive bladder and how are they managed? A population‐based prevalence study
- I. Milsom, P. Abrams, L. Cardozo, R. G. Roberts, J. Thüroff, A. Wein
- MedicineBJU international
- 1 June 2001
The prevalence of chronic and debilitating symptoms of the overactive bladder are determined as the presence of chronic frequency, urgency and urge incontinence (either alone or in any combination), and presumed to be caused by involuntary detrusor contractions.
Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal…
P. Abrams , K.E. Andersson, L. Birder, L. Brubaker, L. Cardozo, C. Chapple, A. Cottenden, W. Davila, D. de Ridder, R. Dmochowski, M. Drake, C. DuBeau, C. Fry, P. Hanno, J. Hay Smith, S. Herschorn, G.…
A new questionnaire to assess the quality of life of urinary incontinent women
- C. Kelleher, L. Cardozo, V. Khullar, S. Salvatore
- MedicineBritish journal of obstetrics and gynaecology
- 1 December 1997
Objectives To design and validate a condition‐specific quality of life questionnaire for the assessment of women with urinary incontinence, and to use the questionnaire to assess the quality of life…
Sacral anterior root stimulators for bladder control in paraplegia: the first 50 cases.
- G. Brindley, C. Polkey, D. Rushton, L. Cardozo
- MedicineJournal of neurology, neurosurgery, and…
- 1 October 1986
The first 50 patients who have received sacral anterior root stimulator implants are presented, with follow-up of from 1 to 9 years. Forty-nine are alive and 43 are regularly using their implants for…
P-QOL: a validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse
- G. Digesu, V. Khullar, L. Cardozo, D. Robinson, S. Salvatore
- MedicineInternational Urogynecology Journal
- 1 May 2005
A P-QOL questionnaire for English-speaking patients has been developed which is reliable and valid and has a highly significant correlation between the total scores for each domain.
Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence.
Direct pairwise comparison and MTC analysis showed that the treatments were more effective than no treatment, and more intensive forms of PFMT appear worthwhile, but further research is required to define an optimal form of more intensive therapy.
META‐ANALYSIS OF ESTROGEN THERAPY IN THE MANAGEMENT OF UROGENITAL ATROPHY IN POSTMENOPAUSAL WOMEN: SECOND REPORT OF THE HORMONES AND UROGENITAL THERAPY COMMITTEE
- L. Cardozo, G. Bachmann, D. McClish, D. Fonda, L. Birgerson
- MedicineObstetrics and gynecology
- 1 October 1998
Estrogen is efficacious in the treatment of urogenital atrophy and low-dose vaginal estradiol preparations are as effective as systemic estrogen therapy in the Treatment of Urogenitalatrophy in postmenopausal women.